Medelis: OncologyCRO

@oncologycro

Medelis is a specialized oncology CRO focused on clinical trials in the US and Europe. We provide oncology expertise and a true partner for your trial.

US and Europe
medelis.com
Joined June 2008
16 Photos and videos Photos and videos

Tweets

You blocked @oncologycro

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @oncologycro

  1. Pinned Tweet
    23 Aug 2018

    CAR T-cell therapies are promising, but side effects in the clinic pose risk. Site training and the execution of a detailed communication plan are critical for patient safety. Here's how we handle -

    2 likes
    Undo
  2. 9 hours ago

    KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma | NEJM

    Undo
  3. Sep 7

    Novel breast cancer therapy candidate enters clinical study

    Undo
  4. Sep 4

    Collateral Damage Of Covid-19: More Than 200 International Cancer Trials Suspended via

    Undo
  5. Sep 2

    Radiomics Based on CECT in Differentiating Kimura Disease From Lymph Node Metastases in Head and Neck:

    Undo
  6. Sep 1

    New targets and technologies for CAR-T cells : Current Opinion in Oncology

    Undo
  7. Aug 31

    A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer

    Undo
  8. Aug 26

    CAR T-Cell Therapy Approved by FDA for Mantle Cell Lymphoma

    Undo
  9. Aug 25

    CAR T-Cell Therapy Helps Young Hockey Fan Ice Pediatric Leukemia | Dana-Farber/Boston Children's via

    1 retweet
    Undo
  10. Aug 24

    Don’t Delay Lung Cancer Immunotherapy Treatment Over Fear of COVID-19

    Undo
  11. Aug 19

    CAR T-Cell Therapy Helps Young Hockey Fan Ice Pediatric Leukemia | Dana-Farber/Boston Children's via

    Undo
  12. Aug 19

    PharmAust clinical trials show monepantel fights COVID-19 infectivity, improves prognosis for canines with cancer via

    Undo
  13. Aug 18

    Minorities Are Underrepresented in COVID-19 Clinical Trials - Cancer Health via

    Undo
  14. Aug 18

    Goals of Cancer Care During COVID-19

    Undo
  15. Aug 17

    Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through...

    Undo
  16. Aug 16

    Lorlatinib Prolongs PFS Over Crizotinib in ALK+ NSCLC, Adds to Existing Data for FDA Submission via

    2 retweets 3 likes
    Undo
  17. Aug 14

    Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents

    Undo
  18. Aug 12

    Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling

    Undo
  19. Aug 11

    Clinical trials for new cancer vaccine could start within three years -

    Undo
  20. Aug 10

    High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma | Blood Advances | American Society of Hematology

    Undo
  21. Aug 7

    Unexpected Hospitalizations Result in Unfavorable Outcomes in Head and Neck Cancer via

    1 like
    Undo

@oncologycro hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·